Codiak Announces Pricing of Initial Public Offering
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Codiak BioSciences, Inc. (“Codiak”), a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the pricing of its initial […]